Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 143


Possible basis for the emergence of H1N1 viruses with pandemic potential from avian hosts.

Koçer ZA, Krauss S, Zanin M, Danner A, Gulati S, Jones JC, Friedman K, Graham A, Forrest H, Seiler J, Air GM, Webster RG.

Emerg Microbes Infect. 2015 Jul;4(7):e40. doi: 10.1038/emi.2015.40.


Influenza virus antigenicity and broadly neutralizing epitopes.

Air GM.

Curr Opin Virol. 2015 Apr;11:113-21. doi: 10.1016/j.coviro.2015.03.006. Review.


Editorial overview: virus-glycan interactions and pathogenesis.

Venkataram Prasad BV, Air GM.

Curr Opin Virol. 2014 Aug;7:v-vi. doi: 10.1016/j.coviro.2014.07.009. No abstract available.


Influenza virus-glycan interactions.

Air GM.

Curr Opin Virol. 2014 Aug;7:128-33. doi: 10.1016/j.coviro.2014.06.004. Review.


Glycan array analysis of influenza H1N1 binding and release.

Gulati S, Lasanajak Y, Smith DF, Cummings RD, Air GM.

Cancer Biomark. 2014 Jan 1;14(1):43-53. doi: 10.3233/CBM-130376.


Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread.

Gulati S, Smith DF, Cummings RD, Couch RB, Griesemer SB, St George K, Webster RG, Air GM.

PLoS One. 2013;8(6):e66325. doi: 10.1371/journal.pone.0066325.


Quantitative comparison of human parainfluenza virus hemagglutinin-neuraminidase receptor binding and receptor cleavage.

Tappert MM, Porterfield JZ, Mehta-D'Souza P, Gulati S, Air GM.

J Virol. 2013 Aug;87(16):8962-70. doi: 10.1128/JVI.00739-13.


Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.

Couch RB, Decker WK, Utama B, Atmar RL, Niño D, Feng JQ, Halpert MM, Air GM.

PLoS One. 2012;7(12):e50830. doi: 10.1371/journal.pone.0050830.


Functional glycomic analysis of human milk glycans reveals the presence of virus receptors and embryonic stem cell biomarkers.

Yu Y, Mishra S, Song X, Lasanajak Y, Bradley KC, Tappert MM, Air GM, Steinhauer DA, Halder S, Cotmore S, Tattersall P, Agbandje-McKenna M, Cummings RD, Smith DF.

J Biol Chem. 2012 Dec 28;287(53):44784-99. doi: 10.1074/jbc.M112.425819.


Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.

Popova L, Smith K, West AH, Wilson PC, James JA, Thompson LF, Air GM.

PLoS One. 2012;7(7):e41895. doi: 10.1371/journal.pone.0041895.


Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.

Li Y, Silamkoti A, Kolavi G, Mou L, Gulati S, Air GM, Brouillette WJ.

Bioorg Med Chem. 2012 Jul 15;20(14):4582-9. doi: 10.1016/j.bmc.2012.05.001.


Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.

Venkatramani L, Johnson ES, Kolavi G, Air GM, Brouillette WJ, Mooers BH.

BMC Struct Biol. 2012 May 6;12:7. doi: 10.1186/1472-6807-12-7.


Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction.

Noronha JM, Liu M, Squires RB, Pickett BE, Hale BG, Air GM, Galloway SE, Takimoto T, Schmolke M, Hunt V, Klem E, García-Sastre A, McGee M, Scheuermann RH.

J Virol. 2012 May;86(10):5857-66. doi: 10.1128/JVI.06901-11.


Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.

Vista ES, Crowe SR, Thompson LF, Air GM, Robertson JM, Guthridge JM, James JA.

Lupus. 2012 Feb;21(2):168-74. doi: 10.1177/0961203311429554.


The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.

Nguyen AT, Feasley CL, Jackson KW, Nitz TJ, Salzwedel K, Air GM, Sakalian M.

Retrovirology. 2011 Dec 7;8:101. doi: 10.1186/1742-4690-8-101.


Influenza neuraminidase.

Air GM.

Influenza Other Respir Viruses. 2012 Jul;6(4):245-56. doi: 10.1111/j.1750-2659.2011.00304.x. Review.


A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses.

Song X, Yu H, Chen X, Lasanajak Y, Tappert MM, Air GM, Tiwari VK, Cao H, Chokhawala HA, Zheng H, Cummings RD, Smith DF.

J Biol Chem. 2011 Sep 9;286(36):31610-22. doi: 10.1074/jbc.M111.274217.


Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.

Air GM, Feng J, Chen T, Joachims ML, James JA, Thompson LF.

J Clin Immunol. 2011 Oct;31(5):900-12. doi: 10.1007/s10875-011-9563-1.


Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.

Crowe SR, Merrill JT, Vista ES, Dedeke AB, Thompson DM, Stewart S, Guthridge JM, Niewold TB, Franek BS, Air GM, Thompson LF, James JA.

Arthritis Rheum. 2011 Aug;63(8):2396-406. doi: 10.1002/art.30388.

Items per page

Supplemental Content

Support Center